Speaking from the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce, Victoria Metaxa, MD, PhD, of King’s College Hospital NHS Foundation Trust, London, UK, highlights the need for intensive care unit space for patients treated with CAR-T therapy. Dr Metaxa raises the potential issue of this in the UK and how it should be considered, especially if clinical trials are being carried out. Dr Metaxa discusses what moving forward means for CAR-T therapy and emphasizes the need for further knowledge to improve treatment.